申请人:E. I. Du Pont de Nemours and Company
公开号:US04859693A1
公开(公告)日:1989-08-22
Antiinflammatory carbinoloimidazoles are provided which have the formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sup.1 and R.sup.2 independently are H, F, Cl, Br, CH.sub.3, CF.sub.3 or S(O).sub.n R.sup.3 where n is 0, 1 or 2 and R.sup.3 is alkyl of 1-4 carbon atoms; R.sup.4 is H or alkyl of 1-4 carbon atoms with the proviso that R.sup.4 is H when m is 2 or 3; and m is 1 to 3. The carbinoloimidazoles are preferably administered as topical antiinflammatory compositions.
提供具有以下公式的抗炎碳醇咪唑类化合物:##STR1##或其药用可接受的盐,其中R.sup.1和R.sup.2独立地为H、F、Cl、Br、CH.sub.3、CF.sub.3或S(O).sub.nR.sup.3,其中n为0、1或2,R.sup.3为1-4个碳原子的烷基;R.sup.4为H或1-4个碳原子的烷基,但当m为2或3时,R.sup.4为H;m为1至3。这些碳醇咪唑类化合物最好作为局部抗炎组合物给予。